- Patent lawsuits with original manufacturers are inevitable.
- Potential negative stakeholder feedback.
- Extreme weather events causing damage to assets and supply chain disruptions.
- Changes in precipitation patterns affecting water supply.
- Rising mean temperatures increasing energy demands and costs.
Tanvex BioPharma, Inc.
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, Tanvex BioPharma, Inc. disclosed greenhouse gas emissions of 3.5K tCO2e/year. By scope: Scope 1: 1.1K tCO2e/year; Scope 2: 2.4K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
3.5K tCO2e/year
2022
Water Usage
2.4K metric tons/year
2022
Waste
98.66 metric tons/year
2022
Energy Use
40.6K GJ/year
2022
📊 Emissions by Scope (2022)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 1.1K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 2.4K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Total waste generated in 2022 was 98.66 metric tons, a decrease of 4.1% compared to 2021.
- Water consumption in 2022 was 2,400 metric tons, a decrease of 7.1% compared to 2021.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce employee turnover to 20%
🌱 ESG Focus Areas
GovernanceProduct QualitySocial CareEnvironmental Sustainability